BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 15977970)

  • 21. Long-term pharmacotherapy for obesity in elderly patients: a retrospective evaluation of medical records from a specialized obesity outpatient clinic.
    Horie NC; Cercato C; Mancini MC; Halpern A
    Drugs Aging; 2010 Jun; 27(6):497-506. PubMed ID: 20524709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of obesity: an update on anti-obesity medications.
    Halpern A; Mancini MC
    Obes Rev; 2003 Feb; 4(1):25-42. PubMed ID: 12608525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials.
    Padwal R; Li SK; Lau DC
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1437-46. PubMed ID: 12975638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of obesity: currently marketed and upcoming agents.
    Bays H; Dujovne C
    Am J Cardiovasc Drugs; 2002; 2(4):245-53. PubMed ID: 14727970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological treatment of obesity.
    Mancini MC; Halpern A
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):377-89. PubMed ID: 16767304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-obesity drugs: a review about their effects and their safety.
    Derosa G; Maffioli P
    Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for obesity in individuals with type 2 diabetes.
    Chukir T; Shukla AP; Saunders KH; Aronne LJ
    Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of obesity: present status.
    Scheen AJ; Lefébvre PJ
    Int J Obes Relat Metab Disord; 1999 Feb; 23 Suppl 1():47-53. PubMed ID: 10193862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination phentermine and topiramate extended release in the management of obesity.
    Alfaris N; Minnick AM; Hopkins CM; Berkowitz RI; Wadden TA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1263-74. PubMed ID: 25958964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological management of obesity in pediatric patients.
    Boland CL; Harris JB; Harris KB
    Ann Pharmacother; 2015 Feb; 49(2):220-32. PubMed ID: 25366340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head-to-head studies evaluating efficacy of pharmaco-therapy for obesity: a systematic review and meta-analysis.
    Neovius M; Johansson K; Rössner S
    Obes Rev; 2008 Sep; 9(5):420-7. PubMed ID: 18208467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term pharmacotherapy for obesity and overweight: updated meta-analysis.
    Rucker D; Padwal R; Li SK; Curioni C; Lau DC
    BMJ; 2007 Dec; 335(7631):1194-9. PubMed ID: 18006966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.
    Norris SL; Zhang X; Avenell A; Gregg E; Schmid CH; Kim C; Lau J
    Arch Intern Med; 2004 Jul; 164(13):1395-404. PubMed ID: 15249348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term drug treatment for obesity: a systematic and clinical review.
    Yanovski SZ; Yanovski JA
    JAMA; 2014 Jan; 311(1):74-86. PubMed ID: 24231879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy of obesity.
    Finer N
    Best Pract Res Clin Endocrinol Metab; 2002 Dec; 16(4):717-42. PubMed ID: 12468417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
    Coutinho W
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.